Randomized Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Diagnostic Yield of EUS-FNB
The investigators' primary outcome measure will assess the diagnostic yield (%) of EUS-FNB (fine-needle biopsy) to provide a final diagnosis of the lesion being sampled. This will be expressed as a percentage.
United States: Institutional Review Board
|UCLA Medical Center||Los Angeles, California 90095-7059|
|California Pacific Medical Center||San Francisco, California 94115|
|Moffit Cancer Center||Tampa, Florida 33612|